Evidence map›Paper›PMID 29800323›Full record

ArticleNucleic acids research2018

Nucleoside analogs to manage sequence divergence in nucleic acid amplification and SNP detection.

Zunyi Yang, Hyo-Joong Kim, Jennifer T Le, Chris McLendon, Kevin M Bradley, Myong-Sang Kim, Daniel Hutter, Shuichi Hoshika, Ozlem Yaren, Steven A Benner

Abstract read
In one paragraph

Article in Nucleic acids research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zunyi YangFoundation for Applied Molecular Evolution (FfAME), 13709 Progress Boulevard, Box 7, Alachua, FL 32615, USA.
Hyo-Joong KimFirebird Biomolecular Sciences LLC, 13709 Progress Blvd, Box 17, Alachua, FL 32615, USA.
Jennifer T LeFoundation for Applied Molecular Evolution (FfAME), 13709 Progress Boulevard, Box 7, Alachua, FL 32615, USA.
Chris McLendonFoundation for Applied Molecular Evolution (FfAME), 13709 Progress Boulevard, Box 7, Alachua, FL 32615, USA.
Kevin M BradleyFoundation for Applied Molecular Evolution (FfAME), 13709 Progress Boulevard, Box 7, Alachua, FL 32615, USA.
Myong-Sang KimFirebird Biomolecular Sciences LLC, 13709 Progress Blvd, Box 17, Alachua, FL 32615, USA.
Daniel HutterFoundation for Applied Molecular Evolution (FfAME), 13709 Progress Boulevard, Box 7, Alachua, FL 32615, USA.
Shuichi HoshikaFoundation for Applied Molecular Evolution (FfAME), 13709 Progress Boulevard, Box 7, Alachua, FL 32615, USA.
Ozlem YarenFoundation for Applied Molecular Evolution (FfAME), 13709 Progress Boulevard, Box 7, Alachua, FL 32615, USA.
Steven A BennerFoundation for Applied Molecular Evolution (FfAME), 13709 Progress Boulevard, Box 7, Alachua, FL 32615, USA.

Funding

Receptors, Ligands, and Catalysts on Demand using Expanded Genetic AlphabetsR42GM115130 · NIGMS · FIREBIRD BIOMOLECULAR SCIENCES, LLC · PI BENNER, STEVEN A, YANG, ZUNYI · 2017 to 2018
$990k
Nucleic Acid Innovations to Manage Pathogen Sequence DivergenceR21AI133567 · NIAID · FOUNDATION FOR APPLIED MOLECULAR EVOLUTN · PI YANG, ZUNYI · 2017 to 2018
$407k
Receptors, Ligands, and Catalysts on Demand using Expanded Genetic AlphabetsR41GM115130 · NIGMS · FIREBIRD BIOMOLECULAR SCIENCES, LLC · PI BENNER, STEVEN A · 2015 to 2015
$150k
NIAID NIH HHS R21 AI133567NIGMS NIH HHS R41 GM115130NIGMS NIH HHS R42 GM115130
6 · The paper itself

Abstract

Described here are the synthesis, enzymology and some applications of a purine nucleoside analog (H) designed to have two tautomeric forms, one complementary to thymidine (T), the other complementary to cytidine (C). The performance of H is compared by various metrics to performances of other 'biversal' analogs that similarly rely on tautomerism to complement both pyrimidines. These include (i) the thermodynamic stability of duplexes that pair these biversals with various standard nucleotides, (ii) the ability of the biversals to support polymerase chain reaction (PCR), (iii) the ability of primers containing biversals to equally amplify targets having polymorphisms in the primer binding site, and (iv) the ability of ligation-based assays to exploit the biversals to detect medically relevant single nucleotide polymorphisms (SNPs) in sequences flanked by medically irrelevant polymorphisms. One advantage of H over the widely used inosine 'universal base' and 'mixed sequence' probes is seen in ligation-based assays to detect SNPs. The need to detect medically relevant SNPs within ambiguous sequences is especially important when probing RNA viruses, which rapidly mutate to create drug resistance, but also suffer neutral drift, the second obstructing simple methods to detect the first. Thus, H is being developed to detect variants of viruses that are rapidly mutating.

Indexed as

Polymerase Chain ReactionPolymorphism, Single NucleotideDNA PrimersIsomerismMutationNucleosidesOligonucleotidesPurinesTemperatureDNA PrimersNucleosidesOligonucleotidesPurines

Identifiers

PMID29800323
PMCPMC6159519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.